Mineralocorticoid Replacement in Addison's Disease
Journal of Clinical Endocrinology & Metabolism (2004)
Plasma renin activity is the most reliable biomarker for guiding fludrocortisone dosing.
Fludrocortisone
Oral tablet (0.1mg)Available in all 50 statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
hormones
Synthetic mineralocorticoid for aldosterone replacement in primary adrenal insufficiency. Also used for orthostatic hypotension and POTS to expand plasma volume.
Only oral mineralocorticoid available
Restores sodium balance and blood pressure
Improves orthostatic symptoms
Essential in adrenal insufficiency
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
Binds mineralocorticoid receptors in the collecting duct, upregulating ENaC and Na+/K+-ATPase, promoting sodium/water reabsorption and potassium excretion. Expands plasma volume and raises blood pressure.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
Clinical evidence
Journal of Clinical Endocrinology & Metabolism (2004)
Plasma renin activity is the most reliable biomarker for guiding fludrocortisone dosing.
Safety profile
FAQ
Synthetic mineralocorticoid for aldosterone replacement in primary adrenal insufficiency. Also used for orthostatic hypotension and POTS to expand plasma volume.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.